Biological field-effect transistor (bioFET) holds a great promise for future point-of-care and homecare medical diagnostics. Still, the unmediated detection of biological events in unprocessed physiological solutions is a great challenge due to high ionic concentrations with Debye length < 1 nm, rendering bioFET insensitive to electrostatic events beyond Debye distance away from the sensing area. This observation entirely removes the possibility of antibody-based recognition layers due to the massive dimension of antibodies, and triggered a vivid pursue for short receptors in order bring the interaction closer to the sensing area. On the other hand, recent reports do demonstrate that adsorbed antibodies are strongly tiled towards the surface, suggesting that binding events occur at a much greater proximity to the sensing area as previously suggested. Herein, the Meta-Nano-Channel (MNC) bioFET is demonstrated for specific, label-free, quantitative and real-time sensing of C-reactive protein (CRP), an important biomarker of inflammation and tissue damage, in unprocessed 0.5 mu l blood and sweat samples with Debye lengths of 0.7 nm and 2.3 nm, respectively. The recognition layer is composed of anti-CRP antibodies. Limit-of-detection of 100 fg/ml and 10 fg/ml are recorded for blood and sweat samples, respectively. A dynamic range of 8 orders of magnitude and with excellent sensitivity and linearity are extracted for both blood and sweat. Hence, high-end sensing in physiological samples is possible with bioFETs provided these are specifically designed to address challenges associated with molecular sensing. These challenges and solutions are discussed in the study.
The pressing need for rapid, direct diagnostic tests for infectious diseases is exemplified by Lyme disease. Human cases of this tick-vectored bacterial infection continue to rise globally, yet the conventional laboratory diagnostic is inadequate in capturing early disease, treatment outcome, and reinfection. Direct detection of a pathogen marker from human biological fluid is a coveted strategy that has, until now, presented immense challenges due to the low circulating burden of the Lyme Borrelia pathogen. The current study demonstrates specific, label-free, quantitative, real-time sensing of Borrelia outer surface protein A (OspA) in 0.5 μL whole blood samples with the recently introduced meta-nano-channel field-effect transistor (MNC-FET) biosensor. The MNC-FET biosensor is specifically designed to address the transduction of nonuniform surface distribution of molecular interactions while maintaining the biomolecules in thermal and electrochemical equilibria. The sensing is performed directly in unprocessed blood and without the conventionally employed premeasurement washings, rendering the proposed technology suitable for a fast, simple, self-use diagnostic kit for Lyme disease. The study demonstrates OspA sensing with a limit of detection of 1 fg/mL, a dynamic range of 8 orders of magnitude, and with excellent sensitivity and linearity. The MNC-FET biosensor is fabricated in a complementary metal-oxide-silicon (CMOS) process ensuring superb electronic grade in terms of noise levels and amplification, robustness, stability, and ultimate miniaturization suitable for future multiplexed sensing. The unique MNC-FET biosensor design addressing challenges associated with molecular sensing, coupled with CMOS technology potential for high volume production of high-end chips, provides a viable technology for a low-cost Lyme disease diagnostic kit with excellent quantitative performance in ultra-small unprocessed blood drops.
Low-cost and easy-to-operate biosensors allow for bacteria detection for on-site and real-time applications. However, current biosensors cannot distinguish between living and dead bacteria, critical in determining the persistence of bacterial contamination. The Meta-Nano-Channel field-effect transistor (MNC FET) is employed. Its design allows the formation of numerous conducting nano-channels each coupled to the sensing area binding events with a different efficiency addressing the challenge of molecular localized gating. The MNC FET is biofunctionalized with a recognition layer composed of E. coli antibodies. Sensing is performed in 0.5 µL drops of Lysogeny Broth (ionic strength of 197 mM, protein-rich background of 200 mg/L), providing a complex food environment, and without either sample pre-processing or pre-measurement washing. Specific, label-free, quantitative, and real-time sensing is demonstrated with a limit-of-detection of a single-bacterium and with excellent linearity and sensitivity. Furthermore, the platform's capacity to distinguish living from dead bacteria is validated by comparing the MNC FET response to living E. coli against populations subjected to thermal denaturation, antibiotic treatment, or metabolic inhibition. The MNC FET distinguishes between living and dead E. coli bacteria with a limit-of-detection of a single-bacterium. This method paves the way for biosensors for the discrimination of bacterial viability.
It was the lowest of R ON *C OFF , the highest of F CO , it was a time of unbridled optimism, it was a time of insurmountable challenge, there was knowledge of the crystalline, and ignorance of the amorphous, elegance in operation, and ugliness in reliability, there was hope with integration, yet despair with power handling, it was going to revolutionize the industry, only to disappear before it had a chance…
Depleted Monolithic Active Pixel Sensor (DMAPS) sensors developed in the Tower Semiconductor 180 nm CMOS imaging process have been designed in the context of the ATLAS ITk upgrade Phase-II at the HL-LHC and for future collider experiments. The “MALTA-Czochralski (MALTA-Cz)” full size DMAPS sensor has been developed with the goal to demonstrate a radiation hard, thin CMOS sensor with high granularity, high hit-rate capability, fast response time and superior radiation tolerance. The design targets radiation hardness of > 10 15 (1 MeV) n eq /cm 2 and 100 Mrad TID. The sensor shall operate as tracking sensor with a spatial resolution of ≈ 10 μm and be able to cope with hit rates in excess of 100 MHz/cm 2 at the LHC bunch crossing frequency of 40 MHz. The 512 × 512 pixel sensor uses small collection electrodes (3.5 μm) to minimize capacitance. The small pixel size (36.4 × 36.4 μm 2 ) provides high spatial resolution. Its asynchronous readout architecture is designed for high hit-rates and fast time response in triggered and trigger-less detector applications. The readout architecture is designed to stream all hit data to the multi-channel output which allows an off-sensor trigger formation and the use of hit-time information for event tagging. The sensor manufacturing has been optimised through process adaptation and special implant designs to allow the manufacturing of small electrode DMAPS on thick high-resistivity p-type Czochralski substrate. The special processing ensures excellent charge collection and charge particle detection efficiency even after a high level of radiation. Furthermore the special implant design and use of a Czochralski substrate improves the sensor's time resolution. This paper presents a summary of sensor design optimisation through process and implant choices and TCAD simulation to model the signal response. Beam and laboratory test results on unirradiated and irradiated sensors have shown excellent detection efficiency after a dose of 2 × 10 15 1 MeV n eq /cm 2 . The time resolution of the sensor is measured to be σ = 2 ns.